'In our opinion, focus should shift toward supporting and enhancing the oversight framework for high-complexity clinical laboratory-developed testing procedures. This can be achieved through a reform of the CLIA, collaborating with other regulatory entities such as CAP, and working closely with state agencies like NYSDOH. This collaborative effort aims to harmonize clinical laboratory testing, ensuring a robust, cost-effective, streamlined, and flexible regulatory ecosystem.'
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0012116#sec004